Clinical Trial Update: Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST) [Phase 1, Phase 2]

View source ↗

Summary

The REALIST trial, investigating stromal cell therapy for acute respiratory distress syndrome, is in Phase 1/Phase 2 and currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Stromal cell therapy (REALIST)

Snippet

Sponsor: Belfast Health and Social Care Trust | Conditions: Acute Respiratory Distress Syndrome | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING